Clinical OMICS

NOV-DEC 2017

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link:

Contents of this Issue


Page 24 of 47

Visit us at the 2017 Association for Molecular Pathology Conference NOVEMBER 15-18 | BOOTH #1519 Don't miss our corporate workshop on Nov. 15th, "Clinical Applications of Liquid Biopsy in the Molecular Analysis of ctDNA in Cancer" When you SEEK exquisite sensitivity from a liquid biopsy Look to Agena's UltraSEEKā„¢ Technology Identify clinically informative muta- tions, including indels from BRAF, EGFR, ERBB2, KRAS, NRAS, and PIK3CA. Detect over 70 mutations at as low as 0.1% variant allele frequency from a single blood draw. Generate results in as fast as a day at a fraction of the cost of NGS. When selecting a method for liquid biopsy testing, it quickly becomes a compromise between sensitivity and genomic coverage. The deciding factors are often between the depth of coverage, cost, and data analysis required. UltraSEEKā„¢ is for Research Use Only. Not for use in diagnostic procedures. For more information visit

Articles in this issue

Links on this page

Archives of this issue

view archives of Clinical OMICS - NOV-DEC 2017